Share on LinkedInShare on LinkedIn

ARTICLE · 28 DECEMBER 2022

Patented Medicines Regulations: The Problem Is Not In Collecting The Data, But In How You Use It!

2022 has seen several big changes to the Patented Medicines Regulations under the Patent Act, which came into force on July 1. These changes have already resulted in significant contention...

GlobalIntellectual Property

2022 has seen several big changes to the Patented Medicines Regulations under the Patent Act, which came into force on July 1. These changes have already resulted in significant contention, both in terms of the practice guidelines issued by the Patented Medicines Price Review Board (PMPRB) which were intended to reflect the new Regulations, as we previously reported, as well as in terms of successful constitutional challenges to the new Regulations in Federal and Quebec Courts. It was recently the turn of the Federal Court of Appeal (FCA) to consider whether provisions in the new Regulations are constitutional, by also considering the PMPRB's mandate to combat excessive prices on patented medicines.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from